seed
Stage
1
Investors
About
Novoron develops small molecule therapies targeting lipoprotein receptors to promote repair and regeneration in the central nervous system, aiming to treat neurodegeneration and spinal cord injuries.
Explore Novoron's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.